NIH-funded research R21 grant

Targeting Neuropeptide S Receptor 1 to Reduce Opioid Dependence

Official title: Neuropeptide S Receptor 1 as a Novel Target for Reducing Opioid Self-Administration and Opioid Relapse

Funded at University of Tennessee Health Sci Ctr · NIH-11036641 · Data updated 2026-11-12

This study is looking at a new way to help people with opioid use disorder by using a special receptor to reduce anxiety and stress, which can lead to cravings for opioids, and it aims to do this without making you feel sleepy like some other treatments do.

More Relapse research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Tennessee Health Sci Ctr
NIH-funded
Lab location1 site (Memphis, United States)
Project startSeptember 15, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$423,500
NIH project number1R21DA062022-01
Project IDNIH-11036641 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals struggling with opioid dependence or those at risk of relapse.

Less likely to help

Patients who are not dependent on opioids or who do not experience anxiety related to opioid withdrawal may not benefit from this research.

What this research studies

This research investigates how Neuropeptide S Receptor 1 (NPSR1) can be targeted to help reduce opioid self-administration and relapse in individuals with opioid use disorder. The approach focuses on using NPS to alleviate anxiety and stress, which are common triggers for opioid-seeking behavior. By activating NPSR1, the research aims to provide an anxiolytic effect without the sedative side effects associated with current treatments. The study will utilize both animal models and human data to explore the effectiveness of this novel treatment strategy.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly reduce opioid cravings and relapse rates in patients with opioid use disorder.

How similar studies have gone: While similar approaches have shown promise in treating alcohol dependence, the specific application of NPS for opioid use disorder is novel and has not been extensively tested.

Where this research is happening

  • University of Tennessee Health Sci Ctr
    Memphis, United States
    Active

Researchers

  • Principal investigator: Tunstall, Brendan — University of Tennessee Health Sci Ctr
  • Study coordinator: Tunstall, Brendan

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.